BetterLife-Carleton University Research Team Secure Mitacs Accelerate Funding to Study the Therapeutic Effect of TD-010 in Chronic Anxiety
Ryan Allway July 24th, 2021 Psychedelics VANCOUVER, British Columbia, July 22, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on developing compounds to treat neurological conditions, is pleased to announce funding of its joint application with Dr. Argel Aguilar-Valles... Read more
Silo Pharma Takes Next Step in Bringing Homing Peptide Tech to $30+ Billion RA Market
Ryan Allway July 23rd, 2021 Psychedelics, Top Story, Uncategorized Rheumatoid arthritis, or RA, is an autoimmune and inflammatory disease that causes painful swelling in joints in the hands, wrists, and knees. While medications can slow the disease and prevent joint deformity, there is no cure for the condition, and... Read more
Meet DELIC, the Premiere Psychedelic and Wellness Edutainment Event and Expo for Newcomers and Veteran Psychonauts, Announces Initial Business Speaker Lineup
Ryan Allway July 22nd, 2021 Psychedelics Two-Day Experiential Experience to Help Scale the Business ofPsychedelic Wellness for the Growing Needs of the Mainstream VANCOUVER, BC, July 22, 2021 /PRNewswire/ – Delic Holdings Inc. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform today announced its initial list of... Read more
Levitee Labs Provides Company Update Following CSE Listing
Ryan Allway July 22nd, 2021 Psychedelics VANCOUVER, BC, July 22, 2021 /CNW/ – Levitee Labs Inc. (CSE: LVT) (the “Company” or “Levitee”) is pleased to provide insight into the Company’s achievements to date, current operations, and strategic initiatives. Levitee has ambitious plans to advance its business following its recent... Read more
Ketamine One’s IRP Clinic Using Innovative NeuroCatch Platform to Measure Brain Function in Injured Veterans The NeuroCatch Platform is a 6-Minute Brain Function Assessment System Licensed by Health Canada as a Class II Medical Device
Ryan Allway July 22nd, 2021 Psychedelics, Top News VANCOUVER, British Columbia, July 22, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased... Read more
Small Pharma Establishes Psychedelic-assisted Therapy Training Program
Ryan Allway July 21st, 2021 Psychedelics Training program established ahead of Phase II clinical trials Phase IIa due to start imminently and Phase IIb expected to commence in 2022 LONDON, July 21, 2021 /PRNewswire/ —  Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma“), a neuropharmaceutical company focused on psychedelic-assisted... Read more
The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia San Diego, California–(Newsfile Corp. – July 21, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp”), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet... Read more
Wake Network, Inc. and the Lieber Institute for Brain Development Announce Research Collaboration
Ryan Allway July 21st, 2021 Psychedelics July 21, 2021 – Wake Network, Inc., a global leader in psilocybin mushroom research, production and the developer of genomics-based integration therapies, is pleased to announce a collaboration with the Lieber Institute for Brain Development (the ” Lieber Institute “), a non-profit research Institution... Read more
PharmaDrug Reports Positive Preclinical Study Results of Cepharanthine to Treat Cancers
Ryan Allway July 16th, 2021 Psychedelics Toronto, Ontario–(Newsfile Corp. – July 14, 2021) – PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs,... Read more
Red Light Holland Expected Merger Partner Creso Pharma Completes Acquisition of Halucenex Life Sciences Inc
Ryan Allway July 16th, 2021 Psychedelics Toronto, Ontario–(Newsfile Corp. – July 15, 2021) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )